Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.
González-Pinto L; Alonso-García I; Blanco-Martín T; Camacho-Zamora P; Fraile-Ribot PA; Outeda-García M; Lasarte-Monterrubio C; Guijarro-Sánchez P; Maceiras R; Moya B; Juan C; Vázquez-Ucha JC; Beceiro A; Oliver A; Bou G;...
Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective.
Sendra E; Fernández-Muñoz A; Zamorano L; Oliver A; Horcajada JP; Juan C; Gómez-Zorrilla S Abstract: Pseudomonas aeruginosa is one of the most common nosocomial pathogens and part of the top...
Differential contribution of PBP occupancy and efflux on the effectiveness of β-lactams at their target site in clinical isolates of Neisseria gonorrhoeae.
López-Argüello S; Alcoceba E; Ordóñez P; Taltavull B; Cabot G; Gomis-Font MA; Oliver A; Moya B Abstract: Neisseria gonorrhoeae exhibits alarming antibiotic resistance trends and poses a significant challenge in...
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection.
Valik JK; Giske CG; Hasan B; Gozalo-Margüello M; Martínez-Martínez L; Premru MM; Martinčič Ž; Beović B; Maraki S; Zacharioudaki M; Kofteridis D; McCarthy K; Paterson D; Cueto M; Morales I;...
Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms.
Fernández-Billón M; Jordana-Lluch E; Llambías-Cabot AE; Gomis-Font MA; Fraile-Ribot P; Torrandell RI; Colman-Vega PJ; Murillo Ó; Macià MD; Oliver A Abstract: New combinations of β-lactams and β-lactamase inhibitors, such as...
The Challenge of Treating Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
Hidalgo-Tenorio C; Bou G; Oliver A; Rodríguez-Aguirregabiria M; Salavert M; Martínez-Martínez L Abstract: Gram-negative multidrug-resistant (MDR) bacteria, including Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa, pose a significant challenge in clinical...
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
Herrera C; Gomis-Font MA; López-Causapé C; Díez-Aguilar M; Fraile-Ribot PA; Cardeñoso LM; Oliver A Abstract: The mechanisms underlying ceftazidime/avibactam resistance development in four ceftazidime/avibactam susceptible/resistant pairs of GES-5-producing ST235 Pseudomonas...
Genomic characterization of MRSA recovered from people with cystic fibrosis during two Spanish multicentre studies (2013 and 2021).
Maruri-Aransolo A; Hernandez-García M; Barbero R; Michelena M; Pastor-Vivero MD; Mondejar-Lopez P; Solé A; Cantón R; Caballero-Pérez JD Abstract: Chronic bronchopulmonary infection due to MRSA in people with cystic fibrosis...
Monitoring of Pseudomonas aeruginosa mutational resistome dynamics using an enrichment panel for direct sequencing of clinical samples.
Cortes-Lara S; Medina-Reatiga P; Barrio-Tofiño ED; Gomis-Font MA; Cabot G; Gómez-Romano F; Ayestarán I; Colomar A; Palou-Rotger A; Oteo-Iglesias J; Campo RD; Cantón R; Horcajada JP; López-Causapé C; Oliver A...
| Authors | Title | Journal | Year |
|---|---|---|---|
| Oliver A, Rojo-Molinero E, Arca-Suarez J, Beşli Y, Bogaerts P, Cantón R, Cimen C, Croughs PD, Denis O, Giske CG, Graells T, Daniel Huang TD, Iorga BI, Karatuna O, Kocsis B, Kronenberg A, López-Causapé C, Malhotra-Kumar S, Martínez LM, Mazzariol A, Meyer S, Naas T, Notermans DW, Oteo-Iglesias J, Pedersen T, Pirš M, Poeta P, Poirel L, Pournaras S, Sundsfjord A, Szabó D, Tambić-Andrašević A, Vatcheva-Dobrevska R, Vitkauskienė A, Jeannot K, ESGARS-ISARPAE members | Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group | Clin Microbiol Infect | 2023 |
| Høiby N, Moser C, Oliver A, Williams C, Ramage G, Borghi E, Azeredo J, Macia MD, ESGB board | To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections - That is the question! The opinion of the ESGB board | Biofilm | 2023 |
| Gomis-Font MA, Clari MA, López-Causapé C, Navarro D, Oliver A | Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa | Antimicrob Agents Chemother | 2023 |
| Hernández-García M, García-Castillo M, Nieto-Torres M, Bou G, Ocampo-Sosa A, Pitart C, Gracia-Ahufinger I, Mulet X, Pascual Á, Tormo N, Oliver A, Ruiz-Garbajosa P, Cantón R | Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain | Eur J Clin Microbiol Infect Dis | 2023 |
| Pérez-Vázquez M, López-Causapé C, Corral-Lugo A, McConnell MJ, Oteo-Iglesias J, Oliver A, Martín-Galiano AJ | Mutation Analysis in Regulator DNA-Binding Regions for Antimicrobial Efflux Pumps in 17,000 Pseudomonas aeruginosa Genomes | Microorganisms | 2023 |
| Adrover-Jaume C, Clemente A, Rodríguez-Urretavizcaya B, Vilaplana L, Marco MP, Rojo-Molinero E, Oliver A, de la Rica R | A paper biosensor for overcoming matrix effects interfering with the detection of sputum pyocyanin with competitive immunoassays | Mikrochim Acta | 2023 |
| Jordana-Lluch E, Barceló IM, Escobar-Salom M, Estévez MA, Zamorano L, Gómez-Zorrilla S, Sendra E, Oliver A, Juan C | The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research | Front Microbiol | 2023 |
| Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A, GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group | Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis | Lancet Reg Health Eur | 2023 |
| Gallardo-Alfaro L, Lorente-Montalvo P, Cañellas M, Carandell E, Oliver A, Rojo E, Riera B, Llobera J, Bulilete O, Balearic COVID-19 Pediatric Primary Care Research Group | Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population | BMC Pediatr | 2023 |
| Becerra-Aparicio F, Gómez-Zorrilla S, Hernández-García M, Gijón D, Siverio A, Berbel D, Sánchez-Carrillo C, Cercenado E, Rivera A, de Malet A, Xercavins M, Ruiz de Gopegui E, Canoura-Fernández L, Martínez JA, Seral C, Del Pozo JL, Cotarelo M, Díaz-Regañón J, Cantón R, Oliver A, Horcajada JP, Ruiz-Garbajosa P | Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project) | J Antimicrob Chemother | 2023 |
| Garcia-Gasalla M, Berman-Riu M, Rodriguez A, Iglesias A, Fraile-Ribot PA, Toledo-Pons N, Pol-Pol E, Ferré-Beltrán A, Artigues-Serra F, Martin-Pena ML, Pons J, Murillas J, Oliver A, Riera M, Ferrer JM | Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition | Cytokine | 2023 |
| Diaz Caballero J, Wheatley RM, Kapel N, López-Causapé C, Van der Schalk T, Quinn A, Shaw LP, Ogunlana L, Recanatini C, Xavier BB, Timbermont L, Kluytmans J, Ruzin A, Esser M, Malhotra-Kumar S, Oliver A, MacLean RC | Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients | Nat Commun | 2023 |
| Tait JR, Harper M, Cortés-Lara S, Rogers KE, López-Causapé C, Smallman TR, Lang Y, Lee WL, Zhou J, Bulitta JB, Nation RL, Boyce JD, Oliver A, Landersdorfer CB | Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance | Antimicrob Agents Chemother | 2023 |
| Agyeman AA, López-Causapé C, Rogers KE, Lucas DD, Cortés-Lara S, Gomis-Font MA, Fraile-Ribot P, Figuerola J, Lang Y, Franklyn ERT, Lee WL, Zhou J, Zhang Y, Bulitta JB, Boyce JD, Nation RL, Oliver A, Landersdorfer CB | Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity | Int J Antimicrob Agents | 2023 |
| Gomis-Font MA, Sastre-Femenia MÀ, Taltavull B, Cabot G, Oliver A | In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa | J Antimicrob Chemother | 2023 |
| Fernández-Billón M, Llambías-Cabot AE, Jordana-Lluch E, Oliver A, Macià MD | Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms | Biofilm | 2023 |
| López-Argüello S, Montaner M, Sayed AR, Oliver A, Bulitta JB, Moya B | Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology | Antimicrob Agents Chemother | 2023 |
| Gual-de-Torrella A, López-Causape C, Alejo-Cancho I, Rojo-Molinero E, Sanchez-García G, Cortés-Lara S, Rodríguez Moral MB, Berdonces-Gonzalez P, Lopez de Goikoetxea MJ, Oliver A | Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital | Infect Control Hosp Epidemiol | 2023 |
| López-Argüello S, Montaner M, Mármol-Salvador A, Velázquez-Escudero A, Docobo-Pérez F, Oliver A, Moya B | Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae | Microbiol Spectr | 2023 |
| Alonso-García I, Vázquez-Ucha JC, Lasarte-Monterrubio C, González-Mayo E, Lada-Salvador P, Vela-Fernández R, Aja-Macaya P, Guijarro-Sánchez P, Rumbo-Feal S, Muíño-Andrade M, Fernández-González A, Martínez-Guitián M, Beceiro A, Rodríguez-Iglesias M, Oliver A, Arca-Suárez J, Galán-Sánchez F, Bou G | Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections | J Antimicrob Chemother | 2023 |
| Escobar-Salom M, Barceló IM, Jordana-Lluch E, Torrens G, Oliver A, Juan C | Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential | FEMS Microbiol Rev | 2023 |
| Santos AL, Beckham JL, Liu D, Li G, van Venrooy A, Oliver A, Tegos GP, Tour JM | Visible-Light-Activated Molecular Machines Kill Fungi by Necrosis Following Mitochondrial Dysfunction and Calcium Overload | Adv Sci (Weinh) | 2023 |
| Cabot G, Kim K, Mark BL, Oliver A, Khajehpour M | Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa | Antimicrob Agents Chemother | 2023 |
| Atamna A, Margalit I, Ayada G, Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodríguez-Baño J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstei Y, Yahav D, ESCMID study group for infections in elderly (ESGIE) | Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study | Infection | 2023 |
| Hernando-Amado S, López-Causapé C, Laborda P, Sanz-García F, Oliver A, Martínez JL | Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds | Microbiol Spectr | 2023 |
| Pintado V, Ruiz-Garbajosa P, Aguilera-Alonso D, Baquero-Artigao F, Bou G, Cantón R, Grau S, Gutiérrez-Gutiérrez B, Larrosa N, Machuca I, Martínez Martínez L, Montero MM, Morte-Romea E, Oliver A, Paño-Pardo JR, Sorlí L | Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gramnegative bacteria | Enferm Infecc Microbiol Clin (Engl Ed) | 2023 |
| Montaner M, Lopez-Argüello S, Oliver A, Moya B | PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability | Microbiol Spectr | 2023 |
| López-Causapé C, Maruri-Aransolo A, Gomis-Font MA, Penev I, Castillo MG, Mulet X, de Dios Caballero J, Campo RD, Cantón R, Oliver A | Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients | Clin Microbiol Infect | 2023 |
| Gracia-Ahufinger I, López-González L, Vasallo FJ, Galar A, Siller M, Pitart C, Bloise I, Torrecillas M, Gijón-Cordero D, Viñado B, Castillo-García J, Campo R, Mulet X, Madueño-Alonso A, Chamizo-López FJ, Arrastia-Erviti M, Galán-Sánchez F, Fernández-Quejo M, Rodríguez-Díaz JC, Gutiérrez-Zufiaurre MN, Rodríguez-Maresca MA, Ortega-Lafont MDP, Yagüe-Guirao G, Chaves-Blanco L, Colomina-Rodríguez J, Vidal-Acuña MR, Portillo ME, Franco-Álvarez de Luna F, Centelles-Serrano MJ, Azcona-Gutiérrez JM, Delgado-Iribarren García Campero A, Rey-Cao S, Muñoz P, Calvo-Montes J, Zboromyrska Y, Grandioso D, Càmara J, Cantón R, Larrosa-Escartín N, Díaz-Regañón J, Martínez-Martínez L | The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018) | Front Microbiol | 2023 |
| Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J | Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial | J Antimicrob Chemother | 2023 |
| Ortiz-Cartagena C, Pablo-Marcos D, Fernández-García L, Blasco L, Pacios O, Bleriot I, Siller M, López M, Fernández J, Aracil B, Fraile-Ribot PA, García-Fernández S, Fernández-Cuenca F, Hernández-García M, Cantón R, Calvo-Montes J, Tomás M | CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases | Microbiol Spectr | 2023 |
| Pablo-Marcos D, Siller M, Agüero J, Álvarez-Justel A, García-Fernández S, de la Fuente SV, Goicoechea P, Rodríguez-Lozano J, Ocampo-Sosa A, Lucas-Fernández J, Fariñas MC, Fernández J, Fraile-Ribot PA, Aracil B, Oteo-Iglesias J, Calvo-Montes J | Are GES carbapenemases underdiagnosed? An allelic discrimination assay for their accurate detection and differentiation | J Microbiol Methods | 2023 |
| Viver T, López-Causapé C, Ribot-Fraile P, Pérez-Mazón C, López-Solé D, Jiménez-Guerra G, Taltavull B, López-López A | The molecular epidemiology of SARS-CoV-2 in the Pityusic Islands shows multiple introductions and fast replacements of variants in a touristic worldwide hot spot | Sci Rep | 2023 |
| Vázquez-Morón S, Iglesias-Caballero M, Lepe JA, Garcia F, Melón S, Marimon JM, García de Viedma D, Folgueira MD, Galán JC, López-Causapé C, Benito-Ruesca R, Alcoba-Florez J, Gonzalez Candelas F, Toro M, Fajardo M, Ezpeleta C, Lázaro F, Pérez Castro S, Cuesta I, Zaballos A, Pozo F, Casas I, On Behalf Of Relecov Network Members | Enhancing SARSCoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network | Int J Mol Sci | 2023 |
| Viñuela L, de Salazar A, Fuentes A, Serrano-Conde E, Falces-Romero I, Pinto A, Portilla I, Masiá M, Peraire J, Gómez-Sirvent JL, Sanchiz M, Iborra A, Baza B, Aguilera A, Olalla J, Espinosa N, Iribarren JA, Martínez-Velasco M, Imaz A, Montero M, Rivero M, Suarez-García I, Maciá MD, Galán JC, Perez-Elias MJ, García-Fraile LJ, Moreno C, Garcia F | Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021 | J Med Virol | 2023 |
| Piñeiro L, Villa L, Salmerón P, Maciá MD, Otero L, Vall-Mayans M, Milagro A, Bernal S, Manzanal A, Ansa I, Cilla G | Genetic Characterization of Non-Lymphogranuloma venereum Chlamydia trachomatis Indicates Distinct Infection Transmission Networks in Spain | Int J Mol Sci | 2023 |
| Macià M, Borghi Elisa, Oliver A | Eurobiofilms 2022: A translational perspective of biofilm-related PERSISTENT infections | Biofilm | 2023 |
| Suárez-Bode, L, López-Causapé, C, Arcay, R, Oliver, A, Mena, A | Whole Genome Sequencing Evidences High Rates of Relapse in Clostridioides difficile Infection Caused by the Epidemic Ribotype 106 | Appl Microbiol | 2023 |
| El Mammery A, Ramírez de Arellano E, Cañada-García JE, Cercenado E, Villar-Gómara L, Casquero-García V, García-Cobos S, Lepe JA, Ruiz de Gopegui E, Calvo-Montes J, Larrosa Escartín N, Cantón R, Pérez-Vázquez M, Aracil B, Oteo-Iglesias J | An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics, EARS-Net Spain (2004-2020) | Front Microbiol | 2023 |
| Gijón D, García-Castillo J, Fernández-López MC, Bou G, Siller M, Calvo-Montes J, Pitart C, Vila J, Torno N, Gimeno C, Cruz H, Ramos H, Mulet X, Oliver A, Ruiz-Garbajosa P, Canton R | In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal | Rev Esp Quimioter | 2023 |
| Cercenado E, Rodríguez-Baño J, Alfonso JL, Calbo E, Escosa L, Fernández-Polo A, García-Rodríguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, Horcajada JP, Larrosa N, Martínez C, Molina J, Nuvials X, Oliver A, Paño-Pardo JR, Pérez-Rodríguez MT, Ramírez P, Rey-Biel P, Vidal P, Retamar-Gentil P | Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP | Enferm Infecc Microbiol Clin (Engl Ed) | 2023 |
| Rivera A, Viñado B, Benito N, Docobo-Pérez F, Fernández-Cuenca F, Fernández-Domínguez J, Guinea J, López-Navas A, Moreno MÁ, Larrosa MN, Oliver A, Navarro F | Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion | Enferm Infecc Microbiol Clin (Engl Ed) | 2023 |
| Larrosa MN, Canut-Blasco A, Benito N, Cantón R, Cercenado E, Docobo-Pérez F, Fernández-Cuenca F, Fernández-Domínguez J, Guinea J, López-Navas A, Moreno MÁ, Morosini MI, Navarro F, Martínez-Martínez L, Oliver A | Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports | Enferm Infecc Microbiol Clin (Engl Ed) | 2023 |
| García-Fernández S, Calvo J, Cercenado E, Suárez-Barrenechea AI, Fernández-Billón M, Castillo FJ, Gálvez-Benítez L, Tubau F, Figueroa Cerón RE, Hernández-Cabezas A, González Romo F, Fariñas MC, Gómez M, Díaz-Regañón J, Cantón R | Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain, SMART 2016-2020 | Rev Esp Quimioter | 2023 |
| Reina J, Iglesias C | Detection of co-infection by Herpes simplex virus type 1 and type 2 in female genital ulcers | Rev Esp Quimioter | 2023 |
| Reina J, González de Herrero E | Alternative viral diagnosis in suspected monkeypox | Rev Esp Quimioter | 2023 |
| Reina J, Iglesias C | Vaccines against monkeypox | Med Clin (Engl Ed) | 2023 |
| Reina J | The new generation of messenger RNA (mRNA) vaccines against influenza | Enferm Infecc Microbiol Clin (Engl Ed) | 2023 |
| Martínez-Pomar N, Cunill V, Segura-Guerrero M, Pol-Pol E, Escobar Oblitas D, Pons J, Ayestarán I, Pruneda PC, Losada I, Toledo-Pons N, García Gasalla M, Ferrer Balaguer JM | Hyperinflammatory Immune Response in COVID-19: Host Genetic Factors in Pyrin Inflammasome and Immunity to Virus in a Spanish Population from Majorca Island | Biomedicines | 2023 |
| Doménech-Sánchez A, Laso E, Albertí S | Environmental surveillance of Pseudomonas aeruginosa in recreational waters in tourist facilities of the Balearic Islands, Spain (2016-2019) | Travel Med Infect Dis | 2023 |
| Villa L, Boga JA, Otero L, Vazquez F, Milagro A, Salmerón P, Vall-Mayans M, Maciá MD, Bernal S, Piñeiro L | Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Chlamydia trachomatis Isolates from Patients with Persistent or Clinical Treatment Failure in Spain | Antibiotics (Basel) | 2023 |
| Gavalda M, Vilchez H, Martin ML, Ruiz E, Ribas MA, Riera M | Endocarditis caused by Neisseria bacilliformis: a case report and review of literature | IDCases | 2023 |
| González-Alsina A, Mateu-Borrás M, Doménech-Sánchez A, Albertí S | Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies | Microorganisms | 2023 |
| González J, de Batlle J, Benítez ID, Torres G, Santisteve S, Targa ADS, Gort-Paniello C, Moncusí-Moix A, Aguilà M, Seck F, Ceccato A, Ferrer R, Motos A, Riera J, Fernández L, Menéndez R, Lorente JÁ, Peñuelas O, Garcia-Gasulla D, Peñasco Y, Ricart P, Abril Palomares E, Aguilera L, Rodríguez A, Boado Varela MV, Beteré B, Pozo-Laderas JC, Solé-Violan J, Salvador-Adell I, Novo MA, Barberán J, Amaya Villar R, Garnacho-Montero J, Gómez JM, Blandino Ortiz A, Tamayo Lomas L, Úbeda A, Catalán-González M, Sánchez-Miralles A, Martínez Varela I, Jorge García RN, Franco N, Gumucio-Sanguino VD, Bustamante-Munguira E, Valdivia LJ, Caballero J, Gallego E, Rodríguez C, Castellanos-Ortega Á, Trenado J, Marin-Corral J, Albaiceta GM, de la Torre MDC, Loza-Vázquez A, Vidal P, Añón JM, Carbajales Pérez C, Sagredo V, Carbonell N, Socias L, Barberà C, Estella A, Diaz E, de Gonzalo-Calvo D, Torres A, Barbé F, CIBERESUCICOVID Project | Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients | Arch Bronconeumol | 2023 |
| Galli F, Bindo F, Motos A, Fernández-Barat L, Barbeta E, Gabarrús A, Ceccato A, Bermejo-Martin JF, Ferrer R, Riera J, Peñuelas O, Lorente JÁ, de Gonzalo-Calvo D, Menéndez R, Gonzalez J, Misuraca S, Palomeque A, Amaya-Villar R, Añón JM, Balan Mariño A, Barberà C, Barberán J, Blandino Ortiz A, Bustamante-Munguira E, Caballero J, Cantón-Bulnes ML, Carbajales Pérez C, Carbonell N, Catalán-González M, de Frutos R, Franco N, Galbán C, Lopez Lago A, Gumucio-Sanguino VD, de la Torre MDC, Díaz E, Estella Á, Gallego Curto E, García-Garmendia JL, Gómez JM, Huerta A, Jorge García RN, Loza-Vázquez A, Marin-Corral J, Martin Delgado MC, Martínez de la Gándara A, Martínez Varela I, Lopez Messa J, M Albaiceta G, Nieto MT, Novo MA, Peñasco Y, Pérez-García F, Pozo-Laderas JC, Ricart P, Sagredo V, Sánchez-Miralles A, Sancho Chinesta S, Roche-Campo F, Socias L, Solé-Violan J, Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Úbeda A, Valdivia LJ, Vidal P, Boado MV, Rodríguez A, Antonelli M, Blasi F, Barbé F, Torres A, CIBERESUCICOVID Project investigators (COV20/00110, ISCIII) | Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients | Intensive Care Med | 2023 |
| Escrihuela-Vidal F, Kaasch AJ, Von Cube M, Rieg S, Kern WV, Seifert H, Song KH, Liao CH, Tilley R, Gott H, Scarborough M, Gordon C, Llewelyn MJ, Kuehl R, Morata L, Soriano A, Edgeworth J, De Gopegui ER, Nsutebu E, Cisneros JM, Fowler VG, Thwaites G, López-Contreras J, Barlow G, Ternavasio-De La Vega HG, Rodríguez-Baño J, López-Cortés LE, International Staphylococcus Aureus Collaboration Study Group, The European Society of Clinical Microbiology and Infectious Diseases Study Group For Bloodstream Infections, Endocarditis And Sepsis | Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort | Clin Microbiol Infect | 2023 |
| Atamna A, Margalit I, Ayada G, Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodríguez-Baño J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstei Y, Yahav D, ESCMID study group for infections in elderly (ESGIE) | Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study | Infection | 2022 |
| Hernando-Amado S, López-Causapé C, Laborda P, Sanz-García F, Oliver A, Martínez JL | Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds | Microbiol Spectr | 2022 |
| Montaner M, Lopez-Argüello S, Oliver A, Moya B | PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability | Microbiol Spectr | 2022 |
| López-Causapé C, Maruri-Aransolo A, Gomis-Font MA, Penev I, Castillo MG, Mulet X, de Dios Caballero J, Campo RD, Cantón R, Oliver A | Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients | Clin Microbiol Infect | 2022 |
| Wheatley RM, Caballero JD, van der Schalk TE, De Winter FHR, Shaw LP, Kapel N, Recanatini C, Timbermont L, Kluytmans J, Esser M, Lacoma A, Prat-Aymerich C, Oliver A, Kumar-Singh S, Malhotra-Kumar S, Craig MacLean R | Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient | Nat Commun | 2022 |
| Chastre J, François B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, Sánchez-García M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS, COMBACTE-MAGNET EVADE Study Group | Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial | Crit Care | 2022 |
| Lopez-Montesinos I, Montero MM, Domene-Ochoa S, López-Causapé C, Echeverria D, Sorlí L, Campillo N, Luque S, Padilla E, Prim N, Grau S, Oliver A, Horcajada JP | Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence | Antibiotics (Basel) | 2022 |
| Barceló IM, Jordana-Lluch E, Escobar-Salom M, Torrens G, Fraile-Ribot PA, Cabot G, Mulet X, Zamorano L, Juan C, Oliver A | Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa | Microbiol Spectr | 2022 |
| Herrera-Espejo S, Del Barrio-Tofiño E, Cebrero-Cangueiro T, López-Causapé C, Álvarez-Marín R, Cisneros JM, Pachón J, Oliver A, Pachón-Ibáñez ME | Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis | Antibiotics (Basel) | 2022 |
| Hernández-García M, García-Castillo M, Melo-Cristino J, Pinto MF, Gonçalves E, Alves V, Vieira AR, Ramalheira E, Sancho L, Diogo J, Ferreira R, Cruz H, Chaves C, Bou G, Cercenado E, Delgado-Valverde M, Oliver A, Pitart C, Rodríguez-Lozano J, Tormo N, Díaz-Regañón J, Pássaro L, Duarte J, Cantón R, STEP and SUPERIOR study groups | In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies) | J Antimicrob Chemother | 2022 |
| Hernández-García M, García-Castillo M, Bou G, Cercenado E, Delgado-Valverde M, Oliver A, Pitart C, Rodríguez-Lozano J, Tormo N, Melo-Cristino J, Pinto MF, Gonçalves E, Alves V, Vieira AR, Ramalheira E, Sancho L, Diogo J, Ferreira R, Cruz H, Chaves C, Duarte J, Pássaro L, Díaz-Regañón J, Cantón R | Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies) | Microbiol Spectr | 2022 |
| Santos AL, van Venrooy A, Reed AK, Wyderka AM, García-López V, Alemany LB, Oliver A, Tegos GP, Tour JM | Hemithioindigo-Based Visible Light-Activated Molecular Machines Kill Bacteria by Oxidative Damage | Adv Sci (Weinh) | 2022 |
| Sanz-García F, Hernando-Amado S, López-Causapé C, Oliver A, Martínez JL | Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa | Microbiol Spectr | 2022 |
| Gual-de-Torrella A, Delgado-Valverde M, Pérez-Palacios P, Oteo-Iglesias J, Rojo-Molinero E, Macià MD, Oliver A, Pascual Á, Fernández-Cuenca F | Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not belonging to high-risk clones | Int J Antimicrob Agents | 2022 |
| Lasarte-Monterrubio C, Fraile-Ribot PA, Vázquez-Ucha JC, Cabot G, Guijarro-Sánchez P, Alonso-García I, Rumbo-Feal S, Galán-Sánchez F, Beceiro A, Arca-Suárez J, Oliver A, Bou G | Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa | J Antimicrob Chemother | 2022 |
| Cerón-Pisa N, Shafiek H, Martín-Medina A, Verdú J, Jordana-Lluch E, Escobar-Salom M, Barceló IM, López-Causapé C, Oliver A, Juan C, Iglesias A, Cosío BG | Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD | Int J Mol Sci | 2022 |
| Puig-Collderram B, Domene-Ochoa S, Salvà-Comas M, Montero MM, Duran X, González JR, Grau S, Oliver A, Horcajada JP, Padilla E, Segura C, Prim N | ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa | Microbiol Spectr | 2022 |
| Gill CM, Oliver A, Fraile-Ribot PA, Nicolau DP | In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa | J Antimicrob Chemother | 2022 |
| Cañada-García JE, Moure Z, Sola-Campoy PJ, Delgado-Valverde M, Cano ME, Gijón D, González M, Gracia-Ahufinger I, Larrosa N, Mulet X, Pitart C, Rivera A, Bou G, Calvo J, Cantón R, González-López JJ, Martínez-Martínez L, Navarro F, Oliver A, Palacios-Baena ZR, Pascual Á, Ruiz-Carrascoso G, Vila J, Aracil B, Pérez-Vázquez M, Oteo-Iglesias J, GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group | CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3 | Front Microbiol | 2022 |
| Santopolo G, Clemente A, Rojo-Molinero E, Oliver A, Noé C, de la Rica R | Rapid Identification and Classification of Pathogens That Produce Carbapenemases and Cephalosporinases with a Colorimetric Paper-Based Multisensor | Anal Chem | 2022 |
| Montero MM, Domene-Ochoa S, López-Causapé C, López-Montesinos I, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Ferrer Alapont L, Grau S, Oliver A, Horcajada JP | Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates | Microbiol Spectr | 2022 |
| Santos AL, Liu D, Reed AK, Wyderka AM, van Venrooy A, Li JT, Li VD, Misiura M, Samoylova O, Beckham JL, Ayala-Orozco C, Kolomeisky AB, Alemany LB, Oliver A, Tegos GP, Tour JM | Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane | Sci Adv | 2022 |
| Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Grier S, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodríguez-Baño J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D | Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study | Infect Dis Ther | 2022 |
| Torrens G, van der Schalk TE, Cortes-Lara S, Timbermont L, Del Barrio-Tofiño E, Xavier BB, Zamorano L, Lammens C, Ali O, Ruzin A, Goossens H, Kumar-Singh S, Kluytmans J, Paling F, MacLean RC, Köhler T, López-Causapé C, Malhotra-Kumar S, Oliver A, ASPIREICU study team | Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial | J Antimicrob Chemother | 2022 |
| Alcoceba E, Gómez A, Lara-Esbrí P, Oliver A, Beltrán AF, Ayestarán I, Muñoz P, Escribano P, Guinea J | Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132FERG11 gene substitution in Spain | Clin Microbiol Infect | 2022 |
| Barceló IM, Torrens G, Escobar-Salom M, Jordana-Lluch E, Capó-Bauzá MM, Ramón-Pallín C, García-Cuaresma D, Fraile-Ribot PA, Mulet X, Oliver A, Juan C | Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence | Microbiol Spectr | 2022 |
| Gato E, Anantharajah A, Arroyo MJ, Artacho MJ, Caballero JD, Candela A, Chudějová K, Constanso IP, Elías C, Fernández J, Jiménez J, Lumbreras P, Méndez G, Mulet X, Pérez-Palacios P, Rodríguez-Sánchez B, Cantón R, Hrabák J, Mancera L, Martínez-Martínez L, Oliver A, Pascual Á, Verroken A, Bou G, Oviaño M | Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software | Front Microbiol | 2022 |
| Mateu-Borrás M, Zamorano L, González-Alsina A, Sánchez-Diener I, Doménech-Sánchez A, Oliver A, Albertí S | Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections | Front Cell Infect Microbiol | 2022 |
| López-Causapé C, Fraile-Ribot PA, Jiménez-Serrano S, Cabot G, Del Barrio-Tofiño E, Prado MC, Linares JM, López A, Hurtado A, Riera E, Serra A, Roselló E, Carbó L, Fernández-Baca MV, Gallegos C, Saurina J, Arteaga E, Salom MM, Salvá A, Nicolau A, González-Candelas F, Comas I, Oliver A | A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands | Front Microbiol | 2022 |
| Gomis-Font MA, Cabot G, López-Argüello S, Zamorano L, Juan C, Moyá B, Oliver A | Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones | J Antimicrob Chemother | 2022 |
| Escobar-Salom M, Torrens G, Jordana-Lluch E, Oliver A, Juan C | Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives | Biol Rev Camb Philos Soc | 2022 |
| Bilal H, Tait JR, Lang Y, Zhou J, Bergen PJ, Peleg AY, Bulitta JB, Oliver A, Nation RL, Landersdorfer CB | Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling | Antimicrob Agents Chemother | 2022 |
| Ruedas-López A, Alonso-García I, Lasarte-Monterrubio C, Guijarro-Sánchez P, Gato E, Vázquez-Ucha JC, Vallejo JA, Fraile-Ribot PA, Fernández-Pérez B, Velasco D, Gutiérrez-Urbón JM, Oviaño M, Beceiro A, González-Bello C, Oliver A, Arca-Suárez J, Bou G | Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections | Antimicrob Agents Chemother | 2022 |
| Pomar CA, Bonet ML, Ferre-Beltrán A, Fraile-Ribot PA, García-Gasalla M, Riera M, Picó C, Palou A | Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution | Biomedicines | 2022 |
| Grimalt JO, Vílchez H, Fraile-Ribot PA, Marco E, Campins A, Orfila J, van Drooge BL, Fanjul F | Spread of SARS-CoV-2 in hospital areas | Environ Res | 2022 |
| Carrera-Salinas A, González-Díaz A, Vázquez-Sánchez DA, Camoez M, Niubó J, Càmara J, Ardanuy C, Martí S, Domínguez MÁ, REIPI/GEIH Study Groups (E Ruiz de Gopegui colaborador) | Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones | Res Microbiol | 2022 |
| Pintado V, Ruiz-Garbajosa P, Aguilera-Alonso D, Baquero-Artigao F, Bou G, Cantón R, Grau S, Gutiérrez-Gutiérrez B, Larrosa N, Machuca I, Martínez Martínez L, Montero MM, Morte-Romea E, Oliver A, Paño-Pardo JR, Sorlí L | Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gramnegative bacteria | Enferm Infecc Microbiol Clin (Engl Ed) | 2022 |
| Larrosa MN, Canut-Blasco A, Benito N, Cantón R, Cercenado E, Docobo-Pérez F, Fernández-Cuenca F, Fernández-Domínguez J, Guinea J, López-Navas A, Moreno MÁ, Morosini MI, Navarro F, Martínez-Martínez L, Oliver A | Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports | Enferm Infecc Microbiol Clin (Engl Ed) | 2022 |
| Reina J, Iglesias C | [EDP-938, a new antiviral with inhibitory activity against the nucleoprotein of the respiratory syncytial virus] | Rev Esp Quimioter | 2022 |
| Reina J, Costa C, Fernández-Billón M | Acute retinal necrosis caused by herpes simplex type 2 | Med Clin (Barc) | 2022 |
| Díaz Pérez D, Reina J, Arcay RM, Osona B | Changes in the incidence and clinical manifestations of paediatric respiratory infections of viral aetiology during the SARS-CoV-2 pandemic | Enferm Infecc Microbiol Clin (Engl Ed) | 2022 |
| Reina J, Iglesias C | [Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination] | Rev Esp Quimioter | 2022 |
| Reina J | [The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued] | Rev Esp Quimioter | 2022 |
| Reina J | Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2 | Rev Clin Esp (Barc) | 2022 |
| Alonso Carballo A, Belzunce Capó JF, Iglesias Escobar C, García Gasalla M | Fever and migratory nodules in the lung | Enferm Infecc Microbiol Clin (Engl Ed) | 2022 |
| Gomila I, Socias A, Socias L, Gutierrez L, Ripoll T, Alarcón FJ, García AB, Barceló B | Cardiac Arrest Following Unsuspected Self-Poisoning With Doxylamine | Ther Drug Monit | 2022 |
| Vidal-Cortés P, Martin-Loeches I, Rodríguez A, Bou G, Cantón R, Diaz E, De la Fuente C, Torre-Cisneros J, Nuvials FX, Salavert M, Aguilar G, Nieto M, Ramírez P, Borges M, Soriano C, Ferrer R, Maseda E, Zaragoza R | Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults | Antibiotics (Basel) | 2022 |
| Vaquer A, Barón E, de la Rica R | Dissolvable Polymer Valves for Sweat Chrono-Sampling in Wearable Paper-Based Analytical Devices | ACS Sens | 2022 |
| Claverias L, Daniel X, Martín-Loeches I, Vidal-Cortez P, Gómez-Bertomeu F, Trefler S, Zaragoza R, Borges-Sa M, Reyes LF, Quindós G, Peman J, Bodí M, Díaz E, Sarvisé C, Pico E, Papiol E, Solé-Violan J, Marín-Corral J, Guardiola JJ, Rodríguez A, GETGAG/SEMICYUC Working Group | Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia | Med Intensiva (Engl Ed) | 2022 |
| Santopolo G, Clemente A, Rojo-Molinero E, Fernández S, Álvarez MC, Oliver A, de la Rica R | Improved cytometric analysis of untouched lung leukocytes by enzymatic liquefaction of sputum samples | Biol Proced Online | 2022 |
| Borges Sa M, Salaverria I, Cabas AC | Fluid therapy in sepsis and septic shock | Medicina Intensiva | 2022 |
| Russell SM, Alba-Patiño A, Vaquer A, Clemente A, de la Rica R | Improving the Quantification of Colorimetric Signals in Paper-Based Immunosensors with an Open-Source Reader | Sensors (Basel) | 2022 |
| Alba-Patiño A, Vaquer A, Barón E, Russell SM, Borges M, de la Rica R | Micro- and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care | Mikrochim Acta | 2022 |
| Socias Crespí L, Gomila Muñiz I, Socias Mir A, Ripoll-Vera T, Elorza Guerrero MÁ, Barceló Martín B | Monitoring free digoxin serum concentrations after injection of digoxin-specific antibody fragments in a man with chronic digoxin poisoning | Emergencias | 2022 |
| Santopolo G, Clemente A, González-Freire M, Russell SM, Vaquer A, Barón E, Aranda M, Socias A, Del Castillo A, Borges M, de la Rica R | Plasma-induced nanoparticle aggregation for stratifying COVID-19 patients according to disease severity | Sens Actuators B Chem | 2022 |
| Vidal-Cortés P, Díaz Santos E, Aguilar Alonso E, Amezaga Menéndez R, Ballesteros MÁ, Bodí MA, Bordejé Laguna ML, Garnacho Montero J, García Sánchez M, López Sánchez M, Martín-Loeches I, Ochagavía Calvo A, Ramírez Galleymore P, Alcántara Carmona S, Andaluz Ojeda D, Badallo Arébalo O, Barrasa González H, Borges Sa M, Castellanos-Ortega Á, Estella Á, Ferrer Roca R, Fraile Gutiérrez V, Fuset Cabanes M, Giménez-Esparza Vich C, González Iglesias C, Hernández-Tejedor A, Igeño Cano JC, Iglesias Posadilla D, Jiménez Rivera JJ, Llanos Jorge C, Llompart-Pou JA, López Camps V, Lorencio Cárdenas C, Marcos Neira P, Martín Delgado MC, Martín-Macho González M, Martín Villén L, Nuvials Casals X, Ortiz Suñer A, Quintana Díaz M, Rascado Sedes P, Recuerda Núñez M, Del Río Carbajo L, Rodríguez Aguirregabiria M, Rodríguez Oviedo A, Seijas Betolaza I, Soriano Cuesta C, Suberviola Cañas B, Vera Ching C, Vidal González Á, Zapata Fenor L, Zaragoza Crespo R | Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units | Med Intensiva (Engl Ed) | 2022 |
| Bargay-Lleonart J, Sarubbo F, Arrizabalaga M, Guerra JM, Borràs J, El Haji K, Flexas M, Perales J, Fernández-Baca V, Gallegos C, Cruz MR, Velasco S, López V, Cruz A, Bautista-Gili A, Jimenez-Marco T, Girona-Llobera E, Vilaplana L, Calonge L, Tena J, Galán MP, Payeras A | Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial | J Clin Med | 2022 |
| del Campo MMG, Vaquer A, de la Rica R | Polymer Components for Paper-Based Analytical Devices | Advanced Materials Technologies | 2022 |
| Ruedas-López A, Alonso García I, Lasarte-Monterrubio C, Guijarro-Sánchez P, Gato E, Vázquez-Ucha JC, Vallejo JA, Fraile-Ribot PA, Fernández-Pérez B, Velasco D, Gutiérrez-Urbón JM, Oviaño M, Beceiro A, González-Bello C, Oliver A, Arca-Suárez J, Bou G | Selection of AmpC β-lactamase variants and metallo-β-lactamases leading to ceftolozane/tazobactam and ceftazidime/avibactam-resistance during treatment of MDR/XDR Pseudomonas aeruginosa infections | Antimicrob Agents Chemother | 2021 |
| Valero A, Rodríguez-Gascón A, Isla A, Barrasa H, Del Barrio-Tofiño E, Oliver A, Canut A, Solinís MÁ | Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis | Pharmaceutics | 2021 |
| Montero MM, Domene-Ochoa S, López-Causapé C, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Ferrer-Alapont L, Angulo-Brunet A, Grau S, Oliver A, Horcajada JP | Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model | Sci Rep | 2021 |
| Gómez-Zorrilla S, Becerra-Aparicio F, López Montesinos I, Ruiz de Gopegui E, Grau I, Pintado V, Padilla B, Benito N, Boix-Palop L, Fariñas MC, Peñaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Durán-Jordá X, Díaz-Regañón J, López-Mendoza D, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP, REIPI/GEIRAS-GEMARA SEIMC ITUBRAS-2 Group | A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections? | Infect Dis Ther | 2021 |
| Shafiek H, Verdú J, Iglesias A, Ramon-Clar L, Toledo-Pons N, Lopez-Causape C, Juan C, Fraile-Ribot P, Oliver A, Cosio BG | Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD | BMJ Open Respir Res | 2021 |
| López MG, Chiner-Oms Á, García de Viedma D, Ruiz-Rodriguez P, Bracho MA, Cancino-Muñoz I, D'Auria G, de Marco G, García-González N, Goig GA, Gómez-Navarro I, Jiménez-Serrano S, Martinez-Priego L, Ruiz-Hueso P, Ruiz-Roldán L, Torres-Puente M, Alberola J, Albert E, Aranzamendi Zaldumbide M, Bea-Escudero MP, Boga JA, Bordoy AE, Canut-Blasco A, Carvajal A, Cilla Eguiluz G, Cordón Rodríguez ML, Costa-Alcalde JJ, de Toro M, de Toro Peinado I, Del Pozo JL, Duchêne S, Fernández-Pinero J, Fuster Escrivá B, Gimeno Cardona C, González Galán V, Gonzalo Jiménez N, Hernáez Crespo S, Herranz M, Lepe JA, López-Causapé C, López-Hontangas JL, Martín V, Martró E, Milagro Beamonte A, Montes Ros M, Moreno-Muñoz R, Navarro D, Navarro-Marí JM, Not A, Oliver A, Palop-Borrás B, Parra Grande M, Pedrosa-Corral I, Pérez González MC, Pérez-Lago L, Pérez-Ruiz M, Piñeiro Vázquez L, Rabella N, Rezusta A, Robles Fonseca L, Rodríguez-Villodres Á, Sanbonmatsu-Gámez S, Sicilia J, Soriano A, Tirado Balaguer MD, Torres I, Tristancho A, Marimón JM, SeqCOVID-Spain consortium, Coscolla M, González-Candelas F, Comas I | The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant | Nat Genet | 2021 |
| Clemente A, Alba-Patiño A, Santopolo G, Barón E, Rojo-Molinero E, Oliver A, Pérez-Bárcena J, Merino de Cos P, Aranda M, Del Castillo A, Socias A, Borges M, de la Rica R | Optimized detection of lung IL-6 via enzymatic liquefaction of low respiratory tract samples: application for managing ventilated patients | Analyst | 2021 |
| García-Gasalla M, Ferrer JM, Fraile-Ribot PA, Ferre-Beltrán A, Rodríguez A, Martínez-Pomar N, Ramon-Clar L, Iglesias A, Losada-López I, Fanjul F, Pou JA, Llompart-Alabern I, Toledo N, Pons J, Oliver A, Riera M, Murillas J | Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission | Can J Infect Dis Med Microbiol | 2021 |
| Montero MM, Domene Ochoa S, López-Causapé C, Luque S, Sorlí L, Campillo N, López Montesinos I, Padilla E, Prim N, Angulo-Brunet A, Grau S, Oliver A, Horcajada JP | Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates | Microbiol Spectr | 2021 |
| Candel FJ, Santerre Henriksen A, Longshaw C, Yamano Y, Oliver A | In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection | Clin Microbiol Infect | 2021 |
| Barceló I, Cabot G, Palwe S, Joshi P, Takalkar S, Periasamy H, Cortés-Lara S, Zamorano L, Sánchez-Diener I, Moya B, Bhagwat S, Patel M, Oliver A | In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy | J Antimicrob Chemother | 2021 |
| Fraile-Ribot PA, Fernández J, Gomis-Font MA, Forcelledo L, Mulet X, López-Causapé C, Oliver A | In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections | Antimicrob Agents Chemother | 2021 |
| Gomila RM, Martorell G, Fraile-Ribot PA, Doménech-Sánchez A, Albertí M, Oliver A, García-Gasalla M, Albertí S | Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity | Open Forum Infect Dis | 2021 |
| Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, Reichmuth ML, Bowen JE, Walls AC, Corti D, Bloom JD, Veesler D, Mateo D, Hernando A, Comas I, González-Candelas F | SeqCOVID-SPAIN consortium (lópez-Causapé C, Oliver A colaboradores), Stadler T, Neher RASpread of a SARS-CoV-2 variant through Europe in the summer of 2020 | Nature | 2021 |
| Arcos SC, Lira F, Robertson L, González MR, Carballeda-Sangiao N, Sánchez-Alonso I, Zamorano L, Careche M, Jiménez-Ruíz Y, Ramos R, Llorens C, González-Muñoz M, Oliver A, Martínez JL, Navas A | Metagenomics Analysis Reveals an Extraordinary Inner Bacterial Diversity in Anisakids (Nematoda: Anisakidae) L3 Larvae | Microorganisms | 2021 |
| Gomis-Font MA, Pitart C, Del Barrio-Tofiño E, Zboromyrska Y, Cortes-Lara S, Mulet X, Marco F, Vila J, López-Causapé C, Oliver A | Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump | Antimicrob Agents Chemother | 2021 |
| Tait JR, Bilal H, Kim TH, Oh A, Peleg AY, Boyce JD, Oliver A, Bergen PJ, Nation RL, Landersdorfer CB | Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model | J Glob Antimicrob Resist | 2021 |
| Cortes-Lara S, Barrio-Tofiño ED, López-Causapé C, Oliver A, GEMARA-SEIMC/REIPI Pseudomonas study Group | Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis | Clin Microbiol Infect | 2021 |
| Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Abdel Fattah M, Haquin J, MacGowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, Morales I, Oliver A, Ruiz de Gopegui E, Cano A, Machuca I, Gozalo-Marguello M, Martinez LM, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D | Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study | J Antimicrob Chemother | 2021 |
| Pelegrin AC, Palmieri M, Mirande C, Oliver A, Moons P, Goossens H, van Belkum | A Pseudomonas aeruginosa: a clinical and genomics update | FEMS Microbiol Rev | 2021 |
| Vázquez-Ucha JC, Rodríguez D, Lasarte-Monterrubio C, Lence E, Arca-Suarez J, Maneiro M, Gato E, Perez A, Martínez-Guitián M, Juan C, Oliver A, Bou G, González-Bello C, Beceiro A | 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics | J Med Chem | 2021 |
| Wheatley R, Diaz Caballero J, Kapel N, de Winter FHR, Jangir P, Quinn A, Del Barrio-Tofiño E, López-Causapé C, Hedge J, Torrens G, Van der Schalk T, Xavier BB, Fernández-Cuenca F, Arenzana A, Recanatini C, Timbermont L, Sifakis F, Ruzin A, Ali O, Lammens C, Goossens H, Kluytmans J, Kumar-Singh S, Oliver A, Malhotra-Kumar S, MacLean C | Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection | Nat Commun | 2021 |
| López-Argüello S, Montaner M, Oliver A, Moya B | Molecular Basis of AmpC β-Lactamase Induction by Avibactam in Pseudomonas aeruginosa: PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants | Int J Mol Sci | 2021 |
| Clemente A, Alba-Patiño A, Santopolo G, Rojo-Molinero E, Oliver A, Borges M, Aranda M, Del Castillo A, de la Rica R | Immunodetection of Lung IgG and IgM Antibodies against SARS-CoV-2 via Enzymatic Liquefaction of Respiratory Samples from COVID-19 Patients | Anal Chem | 2021 |
| Bulilete O, Lorente P, Leiva A, Carandell E, Oliver A, Rojo E, Pericas P, Llobera J | COVID-19 Primary Care Research GroupPanbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care | J Infect | 2021 |
| Cabot G, Lara-Esbrí P, Mulet X, Oliver A | Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples | J Antimicrob Chemother | 2021 |
| Hernández-García M, García-Castillo M, García-Fernández S, Melo-Cristino J, Pinto MF, Gonçalves E, Alves V, Vieira AR, Ramalheira E, Sancho L, Diogo J, Ferreira R, Silva T, Chaves C, Bou G, Cercenado E, Delgado-Valverde M, Oliver A, Pitart C, Rodríguez-LozanoJ, Tormo N, Romano J, Pássaro L, Paixão L, López-Mendoza D, Díaz-Regañón J, Cantón R, STEP and SUPERIOR study groups | Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS | J Antimicrob Chemother | 2021 |
| Arca-Suárez J, Lasarte-Monterrubio C, Rodiño-Janeiro BK, Cabot G, Vázquez-Ucha JC, Rodríguez-Iglesias M, Galán-Sánchez F, Beceiro A, González-Bello C, Oliver A, Bou G | Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections | J Antimicrob Chemother | 2021 |
| Adrover-Jaume C , Rojo-Molinero E , Clemente A , Russell SM , Arranz J , Oliver A , de la Rica R | Mobile origami immunosensors for the rapid detection of urinary tract infections | Analyst | 2021 |
| Santopolo G, Rojo-Molinero E, Clemente A, Borges M, Oliver A, de la Rica R | Bedside Detection of Carbapenemase-Producing Pathogens with Plasmonic Nanosensors | Sensors and Actuators B: Chemical | 2021 |
| Román F, Mendez-Echevarria A, Del Rosal T, Garcia-Vera C, Escosa-Garcia L, Agud M, Chaves F, Gutiérrez-Fernández J, Ruiz de Gopegui E, Ruiz-Carrascoso G, Ruiz-Gallego MDC, Bernet A, Quevedo SM, Fernández-Verdugo AM, Sainz T, Calvo C | Characterization of methicillin-resistant Staphylococcus aureus strains colonizing the nostrils of Spanish children | Microbiology open | 2021 |
| Vilchez HH, Escudero-Sanchez R, Fernandez-Sampedro M, Murillo O, Auñón Á, Rodríguez-Pardo D, Jover-Sáenz A, Del Toro MD, Rico A, Falgueras L, Praena-Segovia J, Guío L, Iribarren JA, Lora-Tamayo J, Benito N, Morata L, Ramirez A, Riera M, Study Group On Osteoarticular Infections Geio, The Spanish Network For Research In Infectious Pathology Reipi | Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study | Antibiotics (Basel) | 2021 |
| Sánchez-López J, Cortés-Cuevas JL, Díez-Aguilar M, López-Causapé C, Cantón R, Morosini MI | Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance | JAC Antimicrob Resist | 2021 |
| Salmerón P, Viñado B, Arando M, Alcoceba E, Romero B, Menéndez B, Bernal S, Idigoras P, Colomina J, Martín-Saco G, Leal-Negredo Á, Torreblanca A, Martínez O, Serra-Pladevall J | Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study | J Antimicrob Chemother | 2021 |
| Juan Carlos Vázquez-Ucha, Alejandro Seoane-Estévez, Bruno Kotska Rodiño-Janeiro, Mónica González-Bardanca, Kelly Conde-Pérez, Marta Martínez-Guitián, Laura Alvarez-Fraga, Jorge Arca-Suárez, Cristina Lasarte-Monterrubio, Marta Gut, Ivo Gut, Miguel Álvarez-Tejado, Marina Oviaño, Alejandro Beceiro, Germán Bou, GEMARA-SEIMC/REIPI Enterobacterales Study Group* (Xavier Mulet, colaborador) | Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales | J Antimicrob Chemother | 2021 |
| Lang Y, Shah NR, Tao X, Reeve SM, Zhou J, Moya B, Sayed ARM, Dharuman S, Oyer J, Copik A, Fleischer B, Shin E, Werkman C, Basso KB, Deveson-Lucas D, Sutaria DS, Megroz M, Kim TH, Loudon-Hossler V, Wright A, Jimenez-Nieves RH, Wallace MJ, Cadet KC, Jiao Y, Boyce JD, LoVullo ED, Schweizer HP, Bonomo RA, Bharatham N, Tsuji BT, Landersdorfer C, Norris MH, Shin BS, Louie A, Balasubramanian V, Lee RE, Drusano GL, Bulitta JB | Combating multidrug-resistant bacteria by integrating a novel target site penetration and receptor binding assay platform into translational modeling | Clinical Pharmacology & Therapeutics | 2021 |
| Martínez-López N, Muñoz-Almagro C, Launes C, Navascués A, Imaz-Pérez M, Reina J, Romero MP, Calvo C, Ruiz-García M, Megias G, Valencia-Ramos J, Otero A, Cabrerizo M | Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020 | Viruses | 2021 |
| Mulet X, Fernández-Esgueva M, Norte C, Zamorano L, Del Barrio-Tofiño E, Oliver A, GEMARA-SEIMC - REIPI Pseudomonas study group | Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study | Enferm Infecc Microbiol Clin (Engl Ed) | 2021 |
| Khorrami S, Garrido C, García M, García I, Mena A | Poor agreement between clinical screening and universal pre-procedure SARS-CoV-2 PCR testing prior to endoscopy | Rev Esp Enferm Dig | 2021 |
| Mensa J, Barberán J, Ferrer R, Borges M, Rascado P, Maseda E, Oliver A, Marco F, Adalia R, Aguilar G, Estella A, León López R, Robles Marcos MS, González de Molina FJ, Serrano García R, Salavert M, Fernández Gómez J, Poliakova Y, Pasquau J, Azanza JR, Bou Arévalo G, LLinares Mondéjar P, Cardinal-Fernández P, Soriano A | Recommendations for antibiotic selection for severe nosocomial infections | Rev Esp Quimioter | 2021 |
| Díaz Pérez D, Reina J, Arcay RM, Osona B | Changes in the incidence and clinical manifestations of paediatric respiratory infections of viral aetiology during the SARS-CoV-2 pandemic | Enferm Infecc Microbiol Clin | 2021 |
| Reina J | Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2 | Rev Clin Esp (Barc) | 2021 |
| Reina J | The new generation of messenger RNA (mRNA) vaccines against influenza | Enferm Infecc Microbiol Clin (Engl Ed) | 2021 |
| Reina J, Arcay RM, Busquets M, Machado H | Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses | Rev Esp Quimioter | 2021 |
| Reina J, Fraile-Ribot P | Impact of spike genetic variants in vaccines against SARS-CoV-2 | Vacunas | 2021 |
| Reina J | Influenza vaccination in the time of SARS-CoV-2 | Med Clin (Engl Ed) | 2021 |
| Reina J, Suarez L, Lara P | Detection of respiratory viruses in patients with suspected SARS-CoV-2 infection | Enferm Infecc Microbiol Clin (Engl Ed) | 2021 |
| Reina J | Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2 | Rev Clin Esp | 2021 |
| Reina J | Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2 | Rev Esp Quimioter | 2021 |
| Buades J, Losada I, González-Moreno J, Peñaranda M, Vilaplana L, Roda N, Rey A, Rodriguez A, Garau M, de Gopegui ER, Serra A, Saurina J, Payeras A | Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old | Vaccines (Basel) | 2021 |
| Sayed ARM, Shah NR, Basso KB, Kamat M, Jiao Y, Moya B, Sutaria DS, Lang Y, Tao X, Liu W, Shin E, Zhou J, Werkman C, Louie A, Drusano GL, Bulitta JB | First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus | Antimicrob Agents Chemother | 2021 |
| Doménech-Sánchez A, Laso E, Genestar E, Berrocal CI | Norovirus outbreak causing gastroenteritis in a hotel in Menorca, Spain | Enferm Infecc Microbiol Clin (Engl Ed) | 2021 |
| Causape CL, Candelas FG, Carmona MT, Palomo AO | Procedures in Clinical Microbiology (number 71, 2nd edition 2021) | Enfermedades Infecciosas y Microbiologia Clinica | 2021 |
| Torres A, Motos A, Riera J, Fernández-Barat L, Ceccato A, Pérez-Arnal R, García-Gasulla D, Peñuelas O, Lorente JA, Rodriguez A, de Gonzalo-Calvo D, Almansa R, Gabarrús A, Menéndez R, Bermejo-Martin JF, Ferrer R, Amaya Villar R, Añón JM, Barberà C, Barberán J, Blandino Ortiz A, Bustamante-Munguira E, Caballero J, Carbajales C, Carbonell N, Catalán-González M, Galbán C, Gumucio-Sanguino VD, de la Torre MDC, Díaz E, Estella Á, Gallego E, García Garmendia JL, Garnacho-Montero J, Gómez JM, Huerta A, Jorge García RN, Loza-Vázquez A, Marin-Corral J, Martínez de la Gándara A, Martínez Varela I, López Messa J, M Albaiceta G, Novo MA, Peñasco Y, Pozo-Laderas JC, Ricart P, Salvador-Adell I, Sánchez-Miralles A, Sancho Chinesta S, Socias L, Solé-Violan J, Suares Sipmann F, Tamayo Lomas L, Trenado J, Barbé F, CIBERESUCICOVID Project (COV20/00110, ISCIII) | The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients | Crit Care | 2021 |
| Reina J, Dueñas J, Fraile P | Utilidad de la sangre seca del talón (tarjeta de Guthrie) en el diagnóstico de infección congénita por enterovirus [Use of dried blood from the heel (Guthrie card) in the diagnosis of congenital enterovirus infection] | An Pediatr (Engl Ed) | 2021 |